The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Wage and hour issues under federal and state law for a North Georgia optical retailer
Conducted due-diligence review of labor and employment issues for a North Georgia optical retailer in connection with the acquisition of a company more
Trademark portfolio management for Spectrum Brands
Manage the extensive trademark portfolio of Spectrum Brands, a global manufacturer of batteries, shavers, hair dryers and other personal care more
Patent counseling for Strategic Diagnostics Inc.
Obtains patents and provides patent counseling for Strategic Diagnostics Inc. ("SDI").  SDI is a leading developer and manufacturer of antibodies, more
License negotiation for an online gaming company
Assisted an online gaming company in connection with their negotiations with a gaming authority with respect to a gaming license. This is an entirely more